Alzheimer Disease & Associated Disorders

Alzheimer Disease & Associated Disorders

阿尔茨海默病及相关疾病

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Alzheimer Disease & Associated Disorders》是由Lippincott Williams and Wilkins Ltd.出版社于1987年创办的英文国际期刊(ISSN: 0893-0341,E-ISSN: 1546-4156),该期刊长期致力于临床神经病学领域的创新研究,主要研究方向为医学-病理学。作为SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0603...%),以发表临床神经病学领域等方向的原创性研究为核心(研究类文章占比95.16%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在62篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Alzheimer Disease & Associated Disorders审稿周期约为 较慢,6-12周 。该刊近年未被列入国际预警名单,年发文量约62篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 62 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CLINICAL NEUROLOGY 临床神经病学 PATHOLOGY 病理学
4区 4区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
4区
CLINICAL NEUROLOGY 临床神经病学 PATHOLOGY 病理学
4区 4区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q3 188 / 277

32.3%

学科:PATHOLOGY SCIE Q3 50 / 88

43.8%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:CLINICAL NEUROLOGY SCIE Q3 170 / 278

39.03%

学科:PATHOLOGY SCIE Q3 53 / 88

40.34%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.1 SJR:0.609 SNIP:0.532
学科类别 分区 排名 百分位
大类:Psychology 小类:Clinical Psychology Q2 137 / 311

56%

大类:Psychology 小类:Gerontology Q2 20 / 39

50%

大类:Psychology 小类:Psychiatry and Mental Health Q3 295 / 567

48%

大类:Psychology 小类:Geriatrics and Gerontology Q3 71 / 116

39%

期刊发文

  • Transcranial Direct Current Stimulation Improves Cognitive Function in Mild to Moderate Alzheimer Disease: A Meta-Analysis.

    Author: Cai M1, Guo Z1, Xing G1,2, Peng H1, Zhou L1,3, Chen H1, McClure MA1, He L1, Xiong L4, He B1, Du F5, Mu Q1,6.

    Journal: Alzheimer Dis Assoc Disord. 2019 Apr-Jun;33(2):170-178. doi: 10.1097/WAD.0000000000000304.

  • Alzheimer Disease-associated Cortical Atrophy Does not Differ Between Chinese and Whites.

    Author: Fan J1,2, Tse M1, Carr JS1, Miller BL1, Kramer JH1, Rosen HJ1, Bonham LW1,3, Yokoyama JS1.

    Journal: Alzheimer Dis Assoc Disord. 2019 May 13. doi: 10.1097/WAD.0000000000000315. [Epub ahead of print]

  • Olfactory Impairment and Hippocampal Volume in a Chinese MCI Clinical Sample.

    Author: Yu HL1, Chen ZJ, Zhao JW, Duan SR, Zhao JK.

    Journal: Alzheimer Dis Assoc Disord. 2019 Apr-Jun;33(2):124-128. doi: 10.1097/WAD.0000000000000305.

  • Benzodiazepine Use and Cognitive Decline in Elderly With Normal Cognition.

    Author: Zhang Y, Zhou XH, Meranus DH, Wang L, Kukull WA.

    Journal: Alzheimer Dis Assoc Disord. 2016 Apr-Jun;30(2):113-7. doi: 10.1097/WAD.0000000000000099.

  • Temporal Trends and Geographic Variations in Dementia Mortality in China Between 2006 and 2012: Multilevel Evidence From a Nationally Representative Sample.

    Author: Yin P, Feng X, Astell-Burt T, Page A, Liu J, Liu Y, Liu S, Wang L, Wang L, Zhou M.

    Journal: Alzheimer Dis Assoc Disord. 2016 Mar 18. [Epub ahead of print]

  • NEDD9 gene polymorphism influences the risk of Alzheimer disease and cognitive function in Chinese older persons.

    Author: Fu Y, He F, Tang NL, Tam CW, Lui VW, Chiu HF, Lam LC.

    Journal: Alzheimer Dis Assoc Disord. 2012 Jan;26(1):88-90. doi: 10.1097/WAD.0b013e3182135ef3.

  • Health Care Utilization and Costs Among Patients With AD With and Without Dysphagia.

    Author: Tian H, Abouzaid S, Sabbagh MN, Chen W, Gabriel S, Kahler KH, Kim E.

    Journal: Alzheimer Dis Assoc Disord. 2012 May 16. [Epub ahead of print]

  • Patient Adherence to Transdermal Rivastigmine After Switching From Oral Donepezil: A Retrospective Claims Database Study.

    Author: Tian H, Abouzaid S, Chen W, Kahler KH, Kim E.

    Journal: Alzheimer Dis Assoc Disord. 2012 Aug 12. [Epub ahead of print]